改良古饮食与中碳水饮食对代谢综合征成人身体成分、肝因子、脂肪因子及内皮微颗粒的影响:随机临床试验研究方案
主要评估体重、身体成分、血清肝因子与脂肪因子水平及内皮微颗粒流式分析,旨在探讨碳水化合物限制饮食对代谢状态的影响。
要点
- 比较改良古饮食与中碳水饮食对代谢综合征患者代谢指标的影响。
- 评估固定饮食计划与热量计算两种饮食实施方式的差异。
- 主要结局包括身体成分、肝因子、脂肪因子及内皮微颗粒。
核心结论
- 本试验旨在确定改良古饮食和中碳水饮食对代谢综合征成人身体成分、肝因子、脂肪因子及内皮微颗粒谱的影响。
- 该研究为首次探讨上述饮食及不同实施方式对该人群上述指标影响的随机对照试验。
研究设计与样本
- 随机分为四组:改良古饮食+热量计算、改良古饮食+固定饮食计划、中碳水饮食+热量计算、中碳水饮食+固定饮食计划,干预10周。
临床怎么用
- 结果可为碳水化合物限制饮食改善代谢状态和预防慢性病提供临床证据。
- 将分析固定饮食计划与热量计算两种饮食实施方式的效果差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic syndrome is a combination of metabolic risk factors causing a pathological condition that increases the risk of non-communicable diseases, such as diabetes and cardiovascular diseases. A variety of dietary approaches have been examined to halt this rapid trend; however, the effects of modified-Paleo diet and medium-carbohydrate diet on inflammation, adipokines, hepatokines, and the profile of endothelial microparticles in individuals with metabolic syndrome have not been investigated in detail. The present study is designed to examine the effect of modified-Paleo and moderate-carbohydrate diet with two delivery modes: "fixed diet plan" vs "calorie counting" on weight, body composition, serum levels of some hepatokines and adipocytokines, and flow cytometric analysis of endothelial microparticles in adults with metabolic syndrome. METHODS: Eighty metabolic syndrome patients will be recruited in this study. They will be randomly allocated to one of the following 4 groups: (1) receiving a modified-Paleo diet with calorie counting, (2) receiving a modified-Paleo diet with a fixed diet plan, (3) receiving a medium-carbohydrate diet with calorie counting, and (4) receiving a medium-carbohydrate diet with a fixed diet plan for 10 weeks. Weight, height, waist circumference, and body composition will be assessed at the study baseline and at the end of the trial. Serum insulin, asprosin, chemerin, FGF-21, CTRP-1, PYY, ghrelin, plasma EMPs (CD31+/CD42b- and CD144+/CD42b-), lipid profile, glycemic indices, hs-CRP, leptin, vitamin C, creatinine and satiety, hunger, fullness, and desire to eat (via visual analog scales) will be measured at the study baseline and at the end of the trial. Insulin resistance and insulin sensitivity will be determined using the HOMA-IR and QUICKI equations. DISCUSSION: To the best of our knowledge, this is the first randomized controlled trial that will determine the effect of modified-Paleo and moderate-carbohydrate diet on weight, body composition, serum levels of some hepatokines and adipocytokines, and the profile of EMPs in adults with metabolic syndrome. Moreover, the effects of different diet delivery modes, including "fixed diet plan" and "calorie counting" will also be analyzed. The results of this trial can provide clinical witnesses on the effectiveness of carbohydrate-restricted diets in ameliorating metabolic status and prevent the development of chronic diseases. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT2016121925267N4 . Registered on 26 July 2017.
引用
- Shemirani F, Fotouhi A, Djafarian K, et al. Effects of modified-Paleo and moderate-carbohydrate diets on body composition, serum levels of hepatokines and adipocytokines, and flow cytometric analysis of endothelial microparticles in adults with metabolic syndrome: a study protocol for a randomized clinical trial. Trials. 2021. PMID: 34593030. doi:10.1186/s13063-021-05612-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。